TAVR vs SAVR for severe aortic stenosis

Clinical Question In adults with asymptomatic severe aortic stenosis and low surgical risk, should transcatheter aortic-valve replacement (TAVR) or surgical aortic-valve replacement (SAVR) be recommended as the preferred initial strategy? Background Management of severe aortic stenosis has evolved rapidly over the past decade, driven largely by the expansion of transcatheter aortic-valve replacement into lower- risk and younger patient populations. While […]

Continue reading »

RSI: Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults

Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults Casey. NEJM. 2025. doi: 10.1056/NEJMoa2511420 Clinical Question Among adults with non‑traumatic critical illness undergoing emergency tracheal intubation in the ED or ICU, how does induction with ketamine (1–2 mg/kg IV, dosed by actual body weight) versus etomidate (0.2–0.3 mg/kg IV, dosed by actual body weight) affect 28‑day mortality? Background Peri-intubation […]

Continue reading »

Clinical Decisions on Beta Blockers After MI

Clinical Question In adults with acute myocardial infarction and preserved left ventricular ejection fraction (LVEF), does initiating beta-blocker therapy at discharge, compared with no beta-blocker therapy, reduce the risk of death or recurrent myocardial infarction?   Background Beta-blockers have long been a cornerstone of post–myocardial infarction care, largely based on trials conducted in the pre-reperfusion era. However, with modern advances […]

Continue reading »
1 2 3 … 12